Bharat Biotech expects regulator's nod for intranasal Covid-19 vaccine in August

Bharat Biotech, which is working on an intranasal Covid-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, chairman and managing director of the company, Krishna Ella said. He said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/PJBugcV
https://ift.tt/ykR9TES